‘Pharma Bro’ Martin Shkreli Is Allegedly Disregarding His Pharmaceutical Industry Ban and His $64.6 Million Penalty – And the FTC Isn’t Pleased

The Federal Trade Commission has a bone to pick with ‘Pharma Bro’ Martin Shkreli – again. Peter Foley/Bloomberg via Getty Images Despite being banned from the pharmaceutical industry after he notoriously hiked the price of a lifesaving drug from $13.50 to $750 in 2015, in addition to serving five years in prison for securities fraud,…

This Is Why Your Hiring Process Isn’t Working

Opinions expressed by Entrepreneur contributors are their own. We’ve all made hiring mistakes. We meet a stellar candidate with all the right experience and technical skills. They look great on paper and interview well. We’re excited to make them an offer and bring them on board. Then just months later, we’re wondering where we went…

How The Best Executives Show Leadership in Times of Uncertainty

Opinions expressed by Entrepreneur contributors are their own. From the coronavirus pandemic to inflation and supply chain disruptions, the past several years have presented significant challenges for businesses. Executives steer the ship through these challenges, yet much of leadership’s work occurs behind the scenes. While executives typically value outcomes over appearances, business leaders should not…

Why Your Business Needs to Consider the 4-Day Workweek — Especially If You’re Serious About Diversity.

Opinions expressed by Entrepreneur contributors are their own. The four-day workweek concept isn’t new. New Zealand and many European countries have proven it successful over recent years. Yet, with the shift to hybrid work and the need for increased flexibility, more companies are rethinking the work week. One study showed that 40% of companies have…

This Flower Company Walked Away From a Major Revenue Driver for a Heartwarming Reason — Now It’s Worth 8 Figures Anyway

Flowers for Dreams co-founder and CEO Steven Dyme never set out to make his mark on the floral industry. Courtesy of Flowers for Dreams Dyme describes his story as “super accidental” — a nontraditional narrative fittingly reminiscent of the brand itself, which bills itself as an “everyday” floral delivery company committed to supporting local charities.…

2 Medical Stocks to Buy Before January Ends and 1 to Sell

With rising global medical requirements and continuous technological advancements, the healthcare industry is poised to remain buoyed in the near term. Therefore, quality medical stocks Abbott Laboratories (ABT) and Varex Imaging (VREX) might be solid buys before January ends. However, avoiding fundamentally weak stock SmileDirectClub (SDC) could be wise. Read on…. shutterstock.com – StockNews The…